Portfolio company
Ohmx.Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides sequencing and multi-omics research services for biotechnology, pharmaceutical and clinical research organisations to support drug discovery and diagnostics development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
Motley Bio
This company develops multi-omic sequencing technology for disease detection and drug discovery services for biotechnology and pharmaceutical firms.
SCellex
This company develops spatial gene sequencing tools and provides RNA sequencing services for researchers in biomedical sciences, pharmaceuticals, and diagnostics.
Tagomics
This biotechnology company develops a multiomic profiling platform to assist biopharma and diagnostic organisations with disease detection, drug development and therapy selection.
Abiosciences
This company provides single-cell genomics and bioinformatics platforms to pharmaceutical companies and researchers for drug target and biomarker discovery.
Wobble Genomics
This company develops full-length RNA sequencing technology for pharmaceutical and diagnostic organisations to improve biomarker discovery, patient stratification and clinical success rates.
Bullseye Bio
This company develops vascularised organoids and automated screening platforms to provide drug discovery services for pharmaceutical, academic and biotechnology organisations.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
